Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2025-12-25 @ 7:24 PM
Study NCT ID:
NCT00016432
Status:
COMPLETED
Last Update Posted:
2011-04-19
First Post:
2001-05-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Sponsor:
NSABP Foundation Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-05
Start Date Type:
None
Primary Completion Date:
2003-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2001-05-06
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-04-18
Last Update Post Date:
2011-04-19
Last Update Post Date Type:
ESTIMATED